become less painful in 3 patients between 7 and 24 months after onset of symptoms and in 2 the plaque has become much softer. In the other 2 patients the plaque had disappeared in 4 and 5 years but the penis is still curved. (c) Cured (4): In all 4 patients the plaque has disappeared and the penis is straight. The resolution took between 15 months and 8 years, the average time being 4 years. Pain was the first symptom to disappear followed by the plaque and then by gradual straightening of the penis. Radiotherapy patients (9): (a) Unchanged (2): These were followed up for 9 months and 13 years. The latter patient was impotent but the foimer remained potent though intercourse was painful. (b) Improved (5): In 3 patients painful intercourse had disappeared in 12, 18 and 24 months after treatment. In 2 the plaque had disappeared and in 2 others it had become smaller; it took between 12 months and 4 years for these changes to occur. In 3 patients the penile curvature persisted but lessened in all 3 over a period of 3-7 years; in one of these patients intercourse again became possible after 3 years as the curvature diminished. (c) Cured (2): This took 19 months and 23 months after the onset of symptoms or 12 months and 20 months after the completion of radiotherapy.
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Discussion
From a review of these patients it appears that the condition is fully manifested when first seen and does not become worse: the natural history is one of gradual resolution, albeit over many months; the first symptom to disappear is pain, followed by disappearance of the plaque and then straightening of the penis. None of the patients treated by radiotherapy showed any improvement within 12 months from the end of treatment, so we do not think that this materially helped the condition or interfered with the natural history of the disease. Of these 21 patients, 6 resolved completely, 10 showed improvement so that they could have intercourse again, and 5 remained unchanged. The average period for resolution was 4 years, so some of the improved patients may yet go on to complete resolution. Calloman (1945) described one patient in whom the condition resolved completely in five years. In 1960 Ashworth described the follow-up of 8 patients over a five-year period; by our criteria he found that 4 showed improvement but that none returned to normal function and he concluded that this condition heralded the end to normal sexual life. Our sei ies of patients does not support this conclusion.
The various papers in the literature do not give enough details for us to compare the treatment described with the natural history of the disease and it could well be that the length of the treatment coincided with the natural process of resolution. We therefore, make a plea that, in reporting response to treatment, authors give exact details of the time taken for such response so that this may be compared with the natural history of the disease. The immunosuppressive properties of antilymphocyte serum (ALS) have now been demonstrated in several animal species (Waksman et al. 1961 , Woodruff & Anderson 1964 , Gray et al. 1966 , Lawson et al. 1966 , Abaza et al. 1966 ). The tesults reported in this work represent the effect on renal transplantation in the dog of antilymphocyte plasma prepared in the sheep. The advantage of the sheep over larger and also smaller animals is that it can be kept within standard laboratory conditions and will conveniently provide an amount of plasma adequate for renal transplantation in the dog. A previous report (Mitchell et al. 1966 ) gave encouraging results. The following questions were investigated: Sheep were immunized subcutaneously every two to three weeks with cell suspensions obtained from mesenteric lymph nodes of exsanguinated dogs. Complete Freund's adjuvant was given with the first injection. After the third or fourth injections blood specimens were obtained and the sheep were boosted one week and bled the next; 500 ml blood was withdrawn on each occasion. The bleeding could be repeated every two weeks providing the red cells were returned. The plasma was stored at -20°C. Fenwal equipment was used throughout and aseptic measures were maintained. Filtration was not necessary at the end. the day of transplantation (blood urea nitrogen normal to the 13th day) and also one week before grafting; no histological evidence of rejection L was seen when the second animal died from anemia on the 6th post-transplant day. The plasma was decomplemented at 56°C for twenty minutes. Absorption with washed dog RBCs reduced the titre to acceptable values when equal quantities of cells and plasma were used (Table 1) . Absorbing three times with one-third quantities had little advantage and was time consuming; leuco-agglutination titres were not reduced appreciably by this method.
The results in 7 dogs given the absorbed ALP are shown in Table 2 . Three to seven days' pretreatment was given. One dog died of renal vein thrombosis and another following early rejection at twelve days; he was the only one requiring blood transfusion during surgery. The dosage of ALP was 1 ml/kg body weight per day. Survival was extended in 3 animals to twenty-three, twentyseven and thirty-five days; 2 are alive more than two hundred days after grafting. ALP was given daily for four months, once weekly for two Leuco-agglutination titres were obtained on all batches. The titres were between 1 in 500 and 1 in 1,000.
Normal sheep serum when injected subcutaneously (0-6 ml/kg body weight per day) over a twoweek period produced no ill effects or histological abnormality in the kidneys. Unmodified ALP was then given subcutaneously daily to mongrel dogs in doses of 0-4-2 ml/kg body weight. Within two days all the animals, except those receiving the lowest dose, became lethargic, anorexic, subsequently severely anemic and died in less than two weeks. Hxemagglutination titres which were as high as 1 in 2,000 were found to be cause of the trouble. Absorption with dog erythrocytes was obviously necessary but it was not done until two renal transplants had been carried out to see whether it was worth while going on. Graft survival was extended when ALP was started on months and then discontinued in the 2 animals still alive. These 2 dogs have normal renal function and no proteinuria. Fig 1 shows the early progress of one of the animals. The amount of ALP was halved on day 27 and the blood utea nitrogen started to rise three days later. It diminished when dosage was increased to the original level but subsequently rose again; then doubling the amount of ALP for four days was associated with a reversal of the rejection reaction. After that the dog remained well and no further evidence of rejection was detected.
Varying amounts of lymphoid infiltration were seen in all kidneys, frequently with absolutely normal tissues in between. Vascular changes were rare but a marked degree of interstitial fibrosis and tubular flattening was noted in cases that rejected. Lymphoid infiltration was on the whole never very prominent. Marked lymphoid deple- tion occurred in the lymph nodes and spleen of all animals but it became less as time went on. PAS staining of the kidney showed slight thickening of glomerular basement membrane in almost all cases even in the animals' own kidneys after only three days' pretreatment. Cellularity of the glomeruli was also a little increased. Immunofluorescent staining using rabbit anti-sheep yglobulin showed linear deposits confined to the glomerular basement membrane in all cases. It did not appear to progress from the first week to six months after transplantation in the dogs which survived. The changes were similar to those of experimental nephrotoxic nephritis of the Masugi type (Steblay 1962) . The lumpy-bumpy collections due to deposition of antigen-antibody complexes which occur in other forms of glomerulonephritis (Dixon et al. 1961) were not seen. It is possible that the similarity of tissue-specific antigens of glomerular basement membrane and lymph node stroma was responsible for the formation of antibodies against glomerular basement membrane following inoculation of lymph node contents. The complication was not progressive but is obviously serious and has to be investigated further. Secondly, Mr Slade understood that some 26 leucoagglutinins had already been discovered. He asked whether there was any immediate hope that specific ALS could be prepared. Mr Fox, in reply, said he knew that ALS had been used by the Edinburgh transplantation team in human renal grafting but obviously he could not answer on their behalf. The agent was immunosuppressive and they, like all others in the field, were facing problems of concentration and purification and side-effects on red cells, platelets and the kidney itself.
ALS was not only strain-but also species-specific. Serum prepared from the lymphoid tissue of one person was effective in other human individuals. Agglutination of lymphoid cells was only one of the effects of the serum. The antibody-forming cells might not be appreciably reduced in number and yet the immunosuppressive activity was maintained, possibly by a blindfolding action or division of the cells into inactive forms.
Mr D W Bracey (Peterborough) showed a filmstrip illustiating Tumours of the Testis and briefly discussed each frame of the filmstrip from the teaching point of view.
Meeting April 25 1968 The following cases were shown: 
